Official ESCRS | European Society of Cataract & Refractive Surgeons
Vienna 2018 Delegate Registration Programme Exhibition Virtual Exhibition Satellites 2018 Survey


escrs app advert


Search Title by author or title

One year outcomes of posterior chamber phakic implantable collamer lens implantation for correction of low-to-moderate myopia

Poster Details

First Author: L.Liu CHINA

Co Author(s):    J. Li                    

Abstract Details


To evaluate the outcomes of posterior chamber phakic Implantable Collamer Lens (ICL) implantationin for low-to-moderate myopic patients.


Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, PRC.


This study included 48 eyes of 27 myopic patients treated with ICL implantation. Inclusion criteria were age between 21 and 45 years, spherical equivalent (SE) between -0.50 D and -6.00 D, and cylinder up to -1.50 D. Data on visual acuity, refraction, and complications were collected at 1 day, 1 week, and 1, 3, 6 and 12 months postoperatively.


At 12 months postoperatively, the mean SE was -0.03±0.05 D, 91.67 % and 100.00 % were within ±0.50 D and ±1.00 D of the targeted correction respectively. Manifest refraction change of -0.07±0.06D occurred from 1 month to 1 year. Compared with the preoperative corrected distance visual acuity (CDVA), 38 eyes (79.17%) had better postoperative uncorrected distance visual acuity (UDVA) and 9 eyes (18.75%) had UDVA equivalent to the preoperative CDVA. One eyes lost 1 line, and no eyes lost >1 line of CDVA. No vision-threatening complications occurred at any time.


ICL implantation for low-to-moderate myopia is safe, accurate, and effective.

Financial Disclosure:


Back to Poster listing